Kids with quiet arthritis may taper meds without Flare-Ups, study finds

This study looked at 62 children with juvenile idiopathic arthritis whose disease was inactive. Researchers tested whether slowly reducing and then stopping their biologic medication was as safe and effective as staying on the full dose for 24 weeks. The goal was to see if tapering could maintain disease control while lowering costs and improving quality of life.